Viemed Healthcare, Inc. (VMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VMD Revenue Growth
Revenue Breakdown (FY 2025)
VMD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
VMD Revenue Analysis (2014–2025)
As of May 8, 2026, Viemed Healthcare, Inc. (VMD) generated trailing twelve-month (TTM) revenue of $286.6 million, reflecting exceptional growth of +27.5% year-over-year. The most recent quarter (Q1 2026) recorded $75.4 million in revenue, down 1.0% sequentially.
Looking at the longer-term picture, VMD's 5-year compound annual growth rate (CAGR) stands at +15.5%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $270.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows VMD's business is primarily driven by Equipment Sales (67%), and Service (33%). With over half of revenue concentrated in Equipment Sales, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LINC (+17.8% YoY), BRT (+2.2% YoY), and EHAB (+3.2% YoY), VMD has outperformed the peer group in terms of revenue growth. Compare VMD vs LINC →
VMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VMDCurrent | $287M | +27.5% | +15.5% | 7.7% | |
 LINC | $518M | +17.8% | +12.1% | 5.8% | |
 BRT | $97M | +2.2% | +28.1% | 11.4% | |
 EHAB | $1.1B | +3.2% | -0.3% | 6.0% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 ADUS | $1.4B | +19.6% | +13.2% | 9.7% |
VMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $270.3M | +20.5% | $155.5M | 57.5% | $20.7M | 7.7% |
| 2024 | $224.3M | +22.5% | $133.2M | 59.4% | $17.9M | 8.0% |
| 2023 | $183.0M | +31.8% | $112.8M | 61.6% | $14.3M | 7.8% |
| 2022 | $138.8M | +18.6% | $84.7M | 61.0% | $8.3M | 5.9% |
| 2021 | $117.1M | -10.8% | $73.4M | 62.7% | $11.6M | 9.9% |
| 2020 | $131.3M | +63.6% | $80.1M | 61.0% | $26.8M | 20.4% |
| 2019 | $80.3M | +23.0% | $56.0M | 69.8% | $8.9M | 11.0% |
| 2018 | $65.3M | +39.1% | $48.6M | 74.4% | $17.0M | 26.1% |
| 2017 | $46.9M | +49.7% | $34.6M | 73.8% | $8.8M | 18.8% |
| 2016 | $31.4M | -9.4% | $18.9M | 60.1% | $383K | 1.2% |
See VMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVMD — Frequently Asked Questions
Quick answers to the most common questions about buying VMD stock.
Is VMD's revenue growth accelerating or slowing?
VMD revenue is accelerating at +27.5% year-over-year, exceeding the 5-year CAGR of +15.5%. TTM revenue reached $287M. Growth momentum has increased versus prior periods.
What is VMD's long-term revenue growth rate?
Viemed Healthcare, Inc.'s 5-year revenue CAGR of +15.5% reflects the sustained expansion pattern. Current YoY growth of +27.5% is above this long-term average.
How is VMD's revenue distributed by segment?
VMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.